239 related articles for article (PubMed ID: 12184806)
1. Transcriptional programs activated by exposure of human prostate cancer cells to androgen.
DePrimo SE; Diehn M; Nelson JB; Reiter RE; Matese J; Fero M; Tibshirani R; Brown PO; Brooks JD
Genome Biol; 2002 Jun; 3(7):RESEARCH0032. PubMed ID: 12184806
[TBL] [Abstract][Full Text] [Related]
2. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes.
Xu LL; Su YP; Labiche R; Segawa T; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Int J Cancer; 2001 May; 92(3):322-8. PubMed ID: 11291065
[TBL] [Abstract][Full Text] [Related]
5. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
[TBL] [Abstract][Full Text] [Related]
6. Androgens down-regulate myosin light chain kinase in human prostate cancer cells.
Léveillé N; Fournier A; Labrie C
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):174-9. PubMed ID: 19429448
[TBL] [Abstract][Full Text] [Related]
7. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
8. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
[TBL] [Abstract][Full Text] [Related]
9. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.
Qi H; Labrie Y; Grenier J; Fournier A; Fillion C; Labrie C
Mol Cell Endocrinol; 2001 Sep; 182(2):181-92. PubMed ID: 11514053
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
11. The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Bratland A; Ragnhildstveit E; Bjørnland K; Andersen K; Maelandsmo GM; Fodstad O; Saatcioglu F; Ree AH
Clin Exp Metastasis; 2003; 20(6):541-7. PubMed ID: 14598888
[TBL] [Abstract][Full Text] [Related]
12. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.
Ripple MO; Henry WF; Schwarze SR; Wilding G; Weindruch R
J Natl Cancer Inst; 1999 Jul; 91(14):1227-32. PubMed ID: 10413424
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.
Cinar B; Koeneman KS; Edlund M; Prins GS; Zhau HE; Chung LW
Cancer Res; 2001 Oct; 61(19):7310-7. PubMed ID: 11585771
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
Blok LJ; Chang GT; Steenbeek-Slotboom M; van Weerden WM; Swarts HG; De Pont JJ; van Steenbrugge GJ; Brinkmann AO
Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
[TBL] [Abstract][Full Text] [Related]
15. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C
Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667
[TBL] [Abstract][Full Text] [Related]
16. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells.
Chen M; Tanner M; Levine AC; Levina E; Ohouo P; Buttyan R
Cell Cycle; 2009 Jan; 8(1):149-57. PubMed ID: 19158486
[TBL] [Abstract][Full Text] [Related]
17. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.
Bebermeier JH; Brooks JD; DePrimo SE; Werner R; Deppe U; Demeter J; Hiort O; Holterhus PM
J Mol Med (Berl); 2006 Nov; 84(11):919-31. PubMed ID: 16932916
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
[TBL] [Abstract][Full Text] [Related]
19. AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation.
Hettel D; Zhang A; Alyamani M; Berk M; Sharifi N
Endocrinology; 2018 Aug; 159(8):2884-2890. PubMed ID: 29850791
[TBL] [Abstract][Full Text] [Related]
20. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
